Co-Founder and Chief Technology Officer at LymphaSense - Baltimore, Maryland, United States
LymphaSense is revolutionizing the way that breast cancer patients are monitored for signs of lymphedema after their cancer treatment. Our product is a biosensor screening device for at-risk patients to detect early signs of lymphedema, a debilitating condition for many women after breast cancer surgery. LymphaSense seeks to improve the lives of breast cancer survivors by enabling patients to monitor their body's reaction to cancer treatment.